Skip to main content
MenuSearch & Directory

15-005 - Diagnostic biomarkers of leukocyte-mediated disease

Researchers

David Ford and Mark Duerr.

Summary

This invention entails the use of recently discovered adducts formed from the reaction of glutathione with 2-halofatty aldehydes as plasma biomarkers of leukocyte-mediated disease and halogen gas exposure. 2-Halofatty aldehydes, such as FALD-GSH, are produced by activated leukocytes, as well as during halogen gas exposure.

Intellectual Property Status

  • U.S. patent pending